Alpha Analytical, Inc. announced the acquisition of Boston Analytical, Inc., a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional products industries.
The acquisition adds to Alpha Analytical’s existing portfolio of testing and analytical services and, at the same time, expands the company into the growing life sciences industry. Boston Analytical will retain its name and all of its existing staff. Gary Feinstein, chief executive officer, and Robert McBride, president of Boston Analytical, will continue in their existing roles.
Headquartered in Westborough, MA, with an office in Mansfield, Alpha Analytical is among the top 18 laboratories in the country. Its core analytical services include air, solid and hazardous waste, ECO/human health risk assessments, sediment, tissue, forensics, storm water, wastewater, and water supply applications. Alpha Analytical also provides a broad range of more specialized analyses in organics, inorganics, trace metals, microbiology and air.
Commenting on the acquistion, Alpha Analytical’s president Mark Woelfel said:”The reputation of Boston Analytical fits perfectly with the quality reputation of Alpha Analytical. This combination, along with the strengths exhibited by both companies in customer service, reliability, and project turn-around-time, will enable the delivery of product and service enhancements to meet the needs of all customers”.